Literature DB >> 12217505

The alveolar macrophage: the Trojan horse of Bacillus anthracis.

Chantal Guidi-Rontani1.   

Abstract

Bacillus anthracis, the causative agent of anthrax, has a particular strategy for invading the host and crossing the alveolar barrier. B. anthracis survives within alveolar macrophages, after germination within the phagolysosome, then enters the external medium where it proliferates. Recent data have shown that edema toxin and lethal toxin are the major genetic determinants mediating the survival of germinated spores within macrophages. Here, recent advances in the analysis of B. anthracis pathogenesis are summarized and future challenges discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217505     DOI: 10.1016/s0966-842x(02)02422-8

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  69 in total

1.  A dynamic dose-response model to account for exposure patterns in risk assessment: a case study in inhalation anthrax.

Authors:  Bryan T Mayer; James S Koopman; Edward L Ionides; Josep M Pujol; Joseph N S Eisenberg
Journal:  J R Soc Interface       Date:  2010-11-10       Impact factor: 4.118

Review 2.  Anthrax lethal and edema toxins in anthrax pathogenesis.

Authors:  Shihui Liu; Mahtab Moayeri; Stephen H Leppla
Journal:  Trends Microbiol       Date:  2014-03-27       Impact factor: 17.079

3.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

4.  Gene expression profiling of primary human type I alveolar epithelial cells exposed to Bacillus anthracis spores reveals induction of neutrophil and monocyte chemokines.

Authors:  J Leland Booth; Elizabeth S Duggan; Vineet I Patel; Wenxin Wu; Dennis M Burian; David C Hutchings; Vicky L White; K Mark Coggeshall; Mikhail G Dozmorov; Jordan P Metcalf
Journal:  Microb Pathog       Date:  2018-04-25       Impact factor: 3.738

5.  Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.

Authors:  Christopher K Cote; Nico Van Rooijen; Susan L Welkos
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

7.  The spore-specific alanine racemase of Bacillus anthracis and its role in suppressing germination during spore development.

Authors:  Olga N Chesnokova; Sylvia A McPherson; Christopher T Steichen; Charles L Turnbough
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

8.  Deterministic models of inhalational anthrax in New Zealand white rabbits.

Authors:  Bradford Gutting
Journal:  Biosecur Bioterror       Date:  2014-02-14

9.  Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection.

Authors:  David E Lowe; Stephen M C Ernst; Christine Zito; Jason Ya; Ian J Glomski
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

10.  Bacillus anthracis spore entry into epithelial cells is an actin-dependent process requiring c-Src and PI3K.

Authors:  Qiong Xue; Sarah A Jenkins; Chunfang Gu; Emanuel Smeds; Qing Liu; Ranga Vasan; Brooke H Russell; Yi Xu
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.